Swiss National Bank’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-184,400
Closed -$717K 2464
2024
Q3
$717K Hold
184,400
﹤0.01% 2345
2024
Q2
$723K Buy
184,400
+10,900
+6% +$46.9K ﹤0.01% 2307
2024
Q1
$727K Hold
173,500
﹤0.01% 2365
2023
Q4
$815K Sell
173,500
-16,900
-9% -$65.8K ﹤0.01% 2342
2023
Q3
$594K Hold
190,400
﹤0.01% 2468
2023
Q2
$874K Buy
190,400
+36,200
+23% +$166K ﹤0.01% 2365
2023
Q1
$763K Sell
154,200
-17,800
-10% -$87.7K ﹤0.01% 2390
2022
Q4
$939K Buy
172,000
+4,600
+3% +$28.2K ﹤0.01% 2377
2022
Q3
$1.09M Hold
167,400
﹤0.01% 2292
2022
Q2
$792K Buy
167,400
+12,400
+8% +$61.1K ﹤0.01% 2481
2022
Q1
$1.08M Buy
155,000
+11,400
+8% +$77.8K ﹤0.01% 2370
2021
Q4
$1.46M Buy
+143,600
New +$1.54M ﹤0.01% 2247

Other funds holding MXCT

Swiss National Bank's MXCT Position: Q4 2024 in Review

Swiss National Bank sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 184,400 shares — an estimated $717K sold.

Swiss National Bank first reported a position in MXCT in Q4 2021 and held it in 12 quarters. The position peaked at $1.46M in Q4 2021. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • Swiss National Bank reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
  • Swiss National Bank sold 184,400 MaxCyte shares in Q4 2024, an estimated $717K.
  • Swiss National Bank first reported a position in MaxCyte in Q4 2021 and held it in 12 quarters.
  • Swiss National Bank's MaxCyte position peaked at $1.46M in Q4 2021.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Swiss National Bank's 13F filing for Q4 2024, filed 10 Feb 2025.